✦ LIBER ✦

Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study

✍ Scribed by T. Ahern; A.-M. Tobin; M. Corrigan; A. Hogan; C. Sweeney; B. Kirby; D. O’Shea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon-like peptide 1 analogue therapy

✍ Hogan, Andrew E.; Gaoatswe, Gadintshware; Lynch, Lydia; Corrigan, Michelle A.; W 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 152 KB

A 5-week study of the pharmacokinetics a

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Beneficial effects of once-daily liraglu

✍ J.-P. Courrèges; T. Vilsbøll; M. Zdravkovic; T. Le-Thi; T. Krarup; O. Schmitz; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

A glucagon-like peptide-1 (GLP-1) recept

✍ S. K. Thondam; D. J. Cuthbertson; B. S. Aditya; I. A. MacFarlane; J. P. Wilding; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The effects of LY2189265, a long-acting

✍ G. E. Umpierrez; T. Blevins; J. Rosenstock; C. Cheng; J. H. Anderson; E. J. Bast 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Efficacy of liraglutide, a glucagon-like

✍ Yuya Fujishima, Norikazu Maeda, Kana Inoue, Susumu Kashine, Hitoshi Nishizawa, A 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 351 KB